Description
GENE EXPRESSION TESTING OY2 DE-OB 675C50029
Base award description: GENE EXPRESSION TESTING
Modification chain · 7 transactions
Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.
- Base2022-10-03+$152,727= $152,727
- Mod P000012023-10-01+$150,196= $302,924
- Mod P000022024-01-11-$80,194= $222,730
- Mod P000032024-10-01+$150,196= $372,926
- Mod P000042025-01-30-$91,479= $281,447
- Mod P000052025-10-01+$150,196= $431,643
- Mod P000062026-02-05-$112,203= $319,440
| Transaction | Action date | This action (delta) | Running total | Description on this transaction |
|---|---|---|---|---|
| Base | 2022-10-03 | +$152,727 | $152,727 | GENE EXPRESSION TESTING |
| Mod P00001· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE | 2023-10-01 | +$150,196 | $302,924 | GENE EXPRESSION TESTING OPTION YEAR ONE |
| Mod P00002· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE | 2024-01-11 | −$80,194 | $222,730 | GENE EXPRESSION TESTING DE-OBLIGATION OF UNUSED FUNDS |
| Mod P00003· EXERCISE AN OPTION | 2024-10-01 | +$150,196 | $372,926 | GENE EXPRESSION TESTING OY2 (675C50029) |
| Mod P00004· OTHER ADMINISTRATIVE ACTION | 2025-01-30 | −$91,479 | $281,447 | GENE EXPRESSION TESTING OY1 DE-OB 675C40001) |
| Mod P00005· EXERCISE AN OPTION | 2025-10-01 | +$150,196 | $431,643 | GENE EXPRESSION TESTING OY3 DE-OB 675C60033 |
| Mod P00006· OTHER ADMINISTRATIVE ACTION | 2026-02-05 | −$112,203 | $319,440 | GENE EXPRESSION TESTING OY2 DE-OB 675C50029 |
Related awards · 11
Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.
Other VA awards to the same recipient (UEI NGBXEJX5GLE9)
| Award | Office · PSC / listing | Net obligations | FY |
|---|---|---|---|
| 36C25726N0419 | 257-NETWORK CONTRACT OFFICE 17 (36C257) · Q301 · REFERENCE LABORATORY TESTING | $127,174 | FY2026 |
| 36C25726N0252 | 257-NETWORK CONTRACT OFFICE 17 (36C257) · Q301 · REFERENCE LABORATORY TESTING | $52,215 | FY2026 |
| 36C25526N0057 | 255-NETWORK CONTRACT OFFICE 15 (36C255) · Q301 · REFERENCE LABORATORY TESTING | $3,454 | FY2026 |
| 36C25526N0054 | 255-NETWORK CONTRACT OFFICE 15 (36C255) · Q301 · REFERENCE LABORATORY TESTING | $24,259 | FY2026 |
| 36C25526N0056 | 255-NETWORK CONTRACT OFFICE 15 (36C255) · Q301 · REFERENCE LABORATORY TESTING | $3,454 | FY2026 |
| 36C25526N0055 | 255-NETWORK CONTRACT OFFICE 15 (36C255) · Q301 · REFERENCE LABORATORY TESTING | $3,116 | FY2026 |
Other recipients under Q301 from 248-NETWORK CONTRACT OFFICE 8 (36C248) (most recent first)
| Award | Recipient | Office | Net obligations | FY |
|---|---|---|---|---|
| 36C24826N0684 | VERACYTE, INC. | 248-NETWORK CONTRACT OFFICE 8 (36C248) | $49,730 | FY2026 |
| 36C24826P0831 | UNIVERSITY OF MIAMI | 248-NETWORK CONTRACT OFFICE 8 (36C248) | $178,265 | FY2026 |
| 36C24826N0548 | D & D LABORATORY LLC | 248-NETWORK CONTRACT OFFICE 8 (36C248) | $14,915 | FY2026 |
| 36C24826P0651 | ROCHE DIAGNOSTICS CORPORATION | 248-NETWORK CONTRACT OFFICE 8 (36C248) | $239,858 | FY2026 |
| 36C24826P0221 | REPROSOURCE FERTILITY DIAGNOSTICS, INC. | 248-NETWORK CONTRACT OFFICE 8 (36C248) | $27,500 | FY2026 |
Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_36C24823F0025_3600_V797D70053_3600 · retrieved 2026-09-26.